Project Grant HT94252410841
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$392K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
This $1,526,245 Project Grant awarded on July 1, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund the "MITOCHONDRIAL INFLAMMATION SYNAPTIC SYSTEMS IMAGING OF NEUROINJURY (MISSION) FOR MILD REPETITIVE TRAUMATIC BRAIN INJURY" research project at the University of Pittsburgh. The project aims to investigate mechanisms and treatments for mild, repetitive traumatic brain injury through research on mitochondrial...
The University of Pittsburgh - Of The Commonwealth System of Higher Education, doing business as The University of Pittsburgh, was awarded a $636,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research on a novel combination therapy targeting growth factor receptor cross talk with epitranscriptomic regulation in glioblastoma, a type of brain cancer, with the goal of developing innovative medical...
The University of Pittsburgh was awarded a $2,806,431.00 Project Grant on July 1, 2023 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to optimize small molecule therapeutics to treat focal segmental glomerulosclerosis. This basic, applied, and advanced biomedical research aims to transform health care by developing innovative and impactful medical solutions for Service Members and the American public. The University of Pittsburgh will...
The University of Pittsburgh was awarded a $313,304 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) on July 1, 2024. The purpose of this 2-year grant is to conduct research on "Endothelial-Targeted Metallothionein Gene Editing to Enable VEGF Therapy in Rescuing Diabetic Pressure Ulcers." The project aims to develop new treatments for diabetic pressure ulcers by investigating gene editing techniques to enhance the...
The University of Pittsburgh received a $1,148,334 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, valid from May 15, 2025 to May 14, 2028, supports the development of viral delivery strategies for targeted hair cell regeneration. This research aims to transform healthcare for military service members and the broader public by exploring innovative approaches to disease prevention, diagnosis,...
The University of Pittsburgh has been awarded a $540,800 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on microparticle delivery of chemokine muteins guiding chemokine receptor engineered Treg for tolerance induction after vascular composite allograft transplant. The 3-year award, which runs from September 15, 2024 to September 14, 2027, will support innovative scientific studies aimed at developing novel...
The University of Pittsburgh - Of The Commonwealth System of Higher Education, doing business as The University of Pittsburgh, received a $724,997.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the project "RECOVERY OF TENDON INJURY BY TARGETING ITS ROOT CAUSE AND ENHANCING TENDON STEM CELLS." The grant period of performance is from July 1, 2023 to June 30, 2026. The project aims to conduct biomedical...
The University of Pittsburgh has been awarded a $747,131 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 10, 2024, supports the development of an Extracorporeal Perfusion System (EPS) for composite tissue regeneration. This research effort aims to advance innovative medical technologies to improve health outcomes for military service members and the broader public. The grant will fund a...
The University of Pittsburgh received a $454,142.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "FERROPTOSIS AS A METABOLIC VULNERABILITY OF CYCLIN E-HIGH OVARIAN CANCER". This 2-year research project, with a performance period from May 2024 to May 2026, aims to investigate metabolic vulnerabilities in a specific type of ovarian cancer. The University of Pittsburgh is the primary...
The University of Pittsburgh was awarded a $1,306,281 Project Grant under the Department of the Army's Military Medical Research and Development program (CFDA 12.420) to conduct the "MITOCHONDRIAL INFLAMMATORY SYNAPTIC SYSTEMS IMAGING OF NEUROINJURY (MISSION) FOR MILD REPETITIVE TRAUMATIC BRAIN INJURY" research project. The award began on July 1, 2024 and is scheduled for completion on June 30, 2028. The project aims to study the mechanisms of mitochondrial inflammation and synaptic...